- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04668989
Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers
September 14, 2021 updated by: CooperVision, Inc.
The main objective of the study is to refit existing soft lens wearers with two different daily disposable contact lens types, Lens A and Lens B, to determine their performance after one week of wear.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective, bilateral eye, double-masked, randomized, 1-week cross-over, daily-wear design involving two different daily disposable lens types.
Each lens type will be worn for approximately one week, during which participants record their subjective lens-wear experience.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Medina, Minnesota, United States, 55340
- Complete Eye Care of Medina
-
-
New York
-
Vestal, New York, United States, 13850
- Sacco Eye Group, PLLC
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Athens Eye Care
-
-
Pennsylvania
-
College, Pennsylvania, United States, 16801
- Nittany Eye Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 18 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Self reports having a full eye examination in the previous two years;
- Anticipates being able to wear the study lenses for at least 8 hours a day, 7 days a week;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Habitually wears soft contact lenses, for the past 3 months minimum;
- Has refractive astigmatism no higher than -0.75DC in each eye;
- Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere -1.00 to -6.00D, 0.25D steps).
Exclusion Criteria:
- Is participating in any concurrent clinical or research study;
- Habitually wears one of the study contact lenses;
- Has any known active* ocular disease and/or infection that contraindicates contact lens wear;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
- Has known sensitivity to the diagnostic sodium fluorescein used in the study;
- Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
- Has undergone refractive error surgery or intraocular surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: stenfilcon A - (Test lens)
Subjects will be randomized to wear test lenses for one week then cross-over to the control lenses for one week.
|
Subjects will be randomized to wear test lenses for one week.
Subjects will be randomized to wear control lenses for one week.
|
|
Active Comparator: kalifilcon A - (Control Lens)
Subjects will be randomized to wear control lenses for one week then cross-over to the test lenses for one week.
|
Subjects will be randomized to wear test lenses for one week.
Subjects will be randomized to wear control lenses for one week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Wettability
Time Frame: Baseline - after 2 hours of lens wear
|
Lens wettability on a 0 to 4 descriptive scale, 0.5 steps (0 - Very poor: Immediately displaying non-wetting areas on the lens surface, immediate drying time, 1 - Poor: Irregular surface appearance, drying time << blink time, 2 - Acceptable: Smooth surface appearance immediately after the blink becoming irregular after a while, drying time ≤ blink time, 3 - Good: Typical soft lens appearance with long drying time, 4 - Excellent: Appearance similar to a healthy cornea with very long drying time)
|
Baseline - after 2 hours of lens wear
|
|
Lens Wettability
Time Frame: 1 week
|
Lens wettability on a 0 to 4 descriptive scale, 0.5 steps (0 - Very poor: Immediately displaying non-wetting areas on the lens surface, immediate drying time, 1 - Poor: Irregular surface appearance, drying time << blink time, 2 - Acceptable: Smooth surface appearance immediately after the blink becoming irregular after a while, drying time ≤ blink time, 3 - Good: Typical soft lens appearance with long drying time, 4 - Excellent: Appearance similar to a healthy cornea with very long drying time)
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lyndon Jones, PhD, Centre for Ocular Research & Education
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Actual)
February 5, 2021
Study Completion (Actual)
February 5, 2021
Study Registration Dates
First Submitted
December 4, 2020
First Submitted That Met QC Criteria
December 10, 2020
First Posted (Actual)
December 16, 2020
Study Record Updates
Last Update Posted (Actual)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 14, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-118
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on stenfilcon A - (Test lens)
-
CooperVision, Inc.CompletedMyopiaUnited States
-
CooperVision, Inc.Completed
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedAstigmatism | Myopia | HyperopiaCanada
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedMyopia | AmetropiaCanada
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompletedPresbyopiaUnited States, Canada
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompletedMyopiaUnited States, Canada
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.CompletedMyopiaUnited States